ZNF217 and acute myeloid leukemia: Compared with the negative control (sh-NC), both sh-ZNF217#1 and sh-ZNF217#2 effectively reduced ZNF217 expression at both mRNA and protein levels in AML cell lines (Figure 3B-C).